| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |